After an extensive needs analysis, WLH partnered with Learning and Development and senior leaders to create and deploy...
Artificial intelligence adoption in pharma isn’t failing because of technology — it’s stalling because leadership behaviors and operating...
Commercial model redesigns have accelerated as customers consolidate and decision‑making shifts to system‑level stakeholders. New strategic account roles...
As 2026 begins, pharmaceutical leaders face significant industry changes, including pricing pressures and evolving customer expectations. Effective strategic...
“We always spend December planning,” a biotech COO told us, “but when January arrives, we’re still in meetings...
After an extensive needs analysis, WLH partnered with Learning and Development and senior leaders to create and deploy...
The US division of a global pharmaceutical company needed to revamp its performance management process and tools to...
After a major corporate reorganization, the medical operations group of a global pharmaceutical corporation sought new synergies through...
External marketplace forces and plans to grow the company through product acquisitions encouraged a growing biotech company to...
A major global medical device company reorganized its Marketing function to bring various business unit marketing teams together...
External marketplace forces encouraged a leading global specialty pharmaceutical company to evaluate its US Market Access strategy and...
WLH’s involvement with a Market Access group’s transformation and competency model development included evaluating the group’s learning strategy...
A privately held pharmaceutical company was preparing for the commercial launch of their first prescription drug. The Executive...
A large animal health company sought to understand why there was huge variability in performance with its key...
A leading global animal health company asked WLH to help create and deploy a human capital strategy. There...
WLH Consulting, Inc. worked with the senior leadership team from one of the largest not-for-profit health plan and...
While a global pharmaceutical company was under a Corporate Integrity Agreement (CIA), an associated brand was issued Risk...